Transperineal MR-Guided Stereotactic Prostate Biopsy Utilizing a Commercially Available Anorectal Biopsy Device

K. Wolter; G. Decker; W. A. Willinek

doi:10.1055/s-0032-1330549

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Inhaltsverzeichnis

Rofo 2013; 185(2): 116-120
DOI: 10.1055/s-0032-1330549

Rapid Communication

Transperineal MR-Guided Stereotactic Prostate Biopsy Utilizing a Commercially Available Anorectal Biopsy Device

Transperineale MR-gesteuerte stereotaktische Prostatabiopsie mithilfe einer kommerziell verfügbaren anorektalen Biopsie-Einheit

Autor*innen

K. Wolter
G. Decker
W. A. Willinek

Abstract

Purpose: To evaluate the feasibility of transperineal MR-guided prostate biopsy using a stereotactical targeting system originally designed for anorectal usage.

Materials and Methods: A commercially available DynaTRIM MR targeting system (Invivo corp., Gainesville FL, USA) originally designed only for anorectal application was used on a 70 cm wide-bore, whole-body 3 Tesla MR-system (Ingenia, Philips Healthcare, Best, NL). Transperineal biopsy was performed following mulitparametric MR imaging for targeting of the lesion.

Results: The anorectal device allowed for correct localization and successful MR-guided transperineal biopsy of the targeted lesion.

Conclusion: MR-guided transperineal biopsy is feasible using a commercially available anorectal stereotactic biopsy device. This may lead to a broader acceptance of this approach for targeted prostate biopsies.

Zusammenfassung

Ziel: Machbarkeit der transperinealen Prostata-Biopsie mit einer MR-gestützten Stereotaxie-Einheit, welche primär für die transrektale Anwendung konzipiert wurde.

Material und Methoden: Eine kommerziell verfügbare DynaTRIM-MR-Stereotaxie-Einheit (Invivo corp., Gainesville FL, USA), initial konzipiert für die transrektale Probeentnahme, wurde an einem 70 cm wide-bore 3 Tesla Ganzkörper-MRT (Ingenia, Philips Healthcare, Best, NL) eingesetzt. Nach Akquisition einer multiparametrischen MRT zur Tumorlokalisation und Interventionsplanung erfolgte eine transperineale Stanzbiopsie.

Ergebnisse: Die transrektale Stereotaxie-Einheit ermöglichte die korrekte Lokalisation und eine technisch erfolgreiche transperineale Probeentnahme mittels MR-gesteuerter Navigation.

Schlussfolgerung: Eine transperineale Stanzbiopsie ist mit einer kommerziell verfügbaren transrektalen Stereotaxie-Einheit unter MR-Navigation durchführbar. Dies kann zu einer besseren Verbreitung der transperinealen Biopsie-Methode führen.

Key words

prostate - interventional MR - technology assessment

Volltext

Referenzen

References
1 Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA: a cancer journal for clinicians 2009; 59: 225-249
2 Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European urology 2011; 59: 61-71
3 Barentsz JO, Richenberg J, Clements R et al. ESUR prostate MR guidelines 2012. European radiology 2012; 22: 746-757
4 Franiel T. Multiparametric magnetic resonance imaging of the prostate – technique and clinical applications. Fortschr Röntgenstr 2011; 183: 607-617
5 Beyersdorff D, Ludemann L, Dietz E et al. Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms. Fortschr Röntgenstr 2011; 183: 456-461
6 Schlemmer HP. Multiparametric MRI of the prostate: method for early detection of prostate cancer?. Fortschr Röntgenstr 2010; 182: 1067-1075
7 Quentin M, Arsov C, Rohlen S et al. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system. Fortschr Röntgenstr 2012; 184: 925-929
8 Franiel T, Stephan C, Erbersdobler A et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding – multiparametric MR imaging for detection and biopsy planning. Radiology 2011; 259: 162-172
9 Futterer JJ, Verma S, Hambrock T et al. High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies. Abdominal imaging 2012; 37: 892-896
10 Miura T, Tanaka K, Shigemura K et al. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. International journal of urology: official journal of the Japanese Urological Association 2008; 15: 457-459
11 Patel U, Dasgupta P, Amoroso P et al. Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU international 2012; 109: 1781-1785
12 Kakehi Y, Naito S. Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan. International journal of urology: official journal of the Japanese Urological Association 2008; 15: 319-321
13 Webb JA, Shanmuganathan K, McLean A. Complications of ultrasound-guided transperineal prostate biopsy. A prospective study. British journal of urology 1993; 72: 775-777
14 Tanaka H, Shinkai M, Jo Y et al. Transrectal ultrasound guided transperineal systematic prostate biopsy. Nihon rinsho Japanese journal of clinical medicine 1998; 56: 2067-2071
15 Abdollah F, Novara G, Briganti A et al. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate?. Urology 2011; 77: 921-925
16 Kawakami S, Yamamoto S, Numao N et al. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. International journal of urology: official journal of the Japanese Urological Association 2007; 14: 719-724
17 Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ journal of surgery 2005; 75: 48-50
18 Roethke M, Anastasiadis AG, Lichy M et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World journal of urology 2012; 30: 213-218
19 Anastasiadis AG, Lichy MP, Nagele U et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. European urology 2006; 50: 738-748 ; discussion 748-739
20 Zangos S, Eichler K, Thalhammer A et al. MR-guided interventions of the prostate gland: a literature review. Fortschr Röntgenstr 2010; 182: 947-953
21 Mueller-Lisse UG , Vorstand der AGURdDR. Urogenital radiology in Deutsche Röntgengesellschaft. Fortschr Röntgenstr 2011; 183: 1114-1115
22 Scheidler J, Weores I, Brinkschmidt C et al. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment. Fortschr Röntgenstr 2012; 184: 130-135